Examqo

Examqo › Examqo library › Anesthesiology › Perioperative medicine

Perioperative arrhythmias

An arrhythmia in theatre is first a sign — of hypoxia, a high carbon dioxide, electrolytes, vagal stimulation or light anaesthesia; begin by judging stability, then correct the cause, and only then choose a drug or a shock.

Why it matters in the exam

The exam asks about new atrial fibrillation during surgery, vagal bradycardia, complete heart block, QT prolongation and torsades de pointes, WPW with atrial fibrillation and the drugs that must not be given in it, SVT and adenosine, and the effect of potassium and magnesium on rhythm. Questions also cover anaesthetic drugs that prolong QT and bradycardia in children.

The first step is to check stability: low blood pressure, confusion in an awake patient, chest pain or heart failure. In an unstable patient with tachycardia a synchronised shock is given (for example 120–200 joules biphasic for atrial fibrillation). In a stable patient with atrial fibrillation, oxygen, volume, potassium and magnesium are corrected, anaesthesia is deepened, and the rate is slowed with a beta blocker or diltiazem. If the fibrillation has lasted more than 48 hours, an atrial clot and anticoagulation must be assessed before conversion to sinus rhythm. In narrow-complex SVT vagal manoeuvres are tried and then adenosine 6 mg by rapid injection, and 12 mg if needed.

Bradycardia in surgery usually comes from peritoneal traction, the oculocardiac reflex, laryngoscopy in a child, a high spinal, a second dose of succinylcholine, remifentanil or dexmedetomidine. The stimulus is stopped and atropine 0.5–1 mg is given, repeatable up to 3 mg; in complete block that does not respond, external pacing or adrenaline is started. QT prolongation is caused by low potassium and magnesium and by drugs such as ondansetron, droperidol, haloperidol, methadone and sevoflurane; torsades de pointes is treated with 2 g of magnesium IV. In WPW with atrial fibrillation, drugs that block the node (adenosine, verapamil, digoxin) must not be given, because impulses pass down the accessory pathway and may cause ventricular fibrillation; procainamide or a synchronised shock is given. In ventricular tachycardia with a pulse and stability, amiodarone 150 mg over 10 minutes is given.

Key points

Summary table

DisorderTreatmentExam point
New atrial fibrillationUnstable: synchronised shock; stable: correct causes and slow the rateMore than 48 hours: assess for clot before conversion
Narrow SVTVagal manoeuvres, adenosine 6 mg then 12 mgRapid injection and flush
BradycardiaStop the stimulus, atropine 0.5–1 mg up to 3 mgThink of the oculocardiac reflex and peritoneal traction
Complete blockExternal pacing, adrenaline or isoprenalineAtropine is less effective
Torsades de pointesMagnesium 2 g, correct potassium, stop QT-prolonging drugsOndansetron and droperidol prolong QT
WPW with atrial fibrillationProcainamide or synchronised shockNot adenosine, verapamil or digoxin
Ventricular tachycardia with a pulseUnstable: synchronised shock; stable: amiodarone 150 mg over 10 minutesPulseless: the resuscitation protocol

In the full version for subscribers

The full version is open to subscribers of: Anesthesiology, Internal medicine.

Subscriber? Read the full topic Plans and prices 25 free questions

Sources

Sources are given for further reading; the text is written afresh and not copied from them.

Reviewed by the Examqo AI Professor · 2026-11-02. The text may contain errors; when in doubt, check the source.